Global $1.5 Billion Vial Adaptors for Reconstitution Drug Markets, 2012-2019 & 2020-2027

DUBLIN, Nov. 30, 2020 /PRNewswire/ -- The "Vial Adaptors for Reconstitution Drug - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Vial Adaptors for Reconstitution Drug Market to Reach $1.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Vial Adaptors for Reconstitution Drug estimated at US$1 Billion in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027.

Polycarbonate, one of the segments analyzed in the report, is projected to record a 6.8% CAGR and reach US$913.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Silicon segment is readjusted to a revised 4% CAGR for the next 7-year period.

The U. S. Market is Estimated at $296.1 Million, While China is Forecast to Grow at 5.7% CAGR

The Vial Adaptors for Reconstitution Drug market in the U. S. is estimated at US$296.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$266.5 Million by the year 2027 trailing a CAGR of 5.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.9% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Polyethylene Teraphthalate Glycol Segment to Record 5.3% CAGR

In the global Polyethylene Teraphthalate Glycol segment, USA, Canada, Japan, China and Europe will drive the 5.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$68.6 Million in the year 2020 will reach a projected size of US$98.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$174.5 Million by the year 2027.

The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

• Baxter International, Inc.
• Becton, Dickinson and Company
• Cardinal Health, Inc.
• Sensile Medical AG
• Unilife Corporation
• West Pharmaceutical Services, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Global Competitor Market Shares
• Vial Adaptors for Reconstitution Drug Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

• Market Facts & Figures
• Vial Adaptors for Reconstitution Drug Market Share (in %) by Company: 2019 & 2025
• Market Analytics
• Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
•  Historic Review for Vial Adaptors for Reconstitution Drug by Material - Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
• 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Material - Percentage Breakdown of Value Sales for Polycarbonate, Silicon, Polyethylene Teraphthalate Glycol, Polyethylene and Other Materials for the Years 2012, 2020 & 2027
• Current & Future Analysis for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
• Historic Review for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
• 15-Year Perspective for Vial Adaptors for Reconstitution Drug by Therapeutic Area - Percentage Breakdown of Value Sales for Autoimmune Diseases, Infectious Diseases, Metabolic Conditions, Reproductive Health and Other Therapeutic Areas for the Years 2012, 2020 & 2027

IV. COMPETITION

• Total Companies Profiled: 46

For more information about this report visit https://www.researchandmarkets.com/r/szjb6w

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-1-5-billion-vial-adaptors-for-reconstitution-drug-markets-2012-2019--2020-2027--301181793.html

SOURCE Research and Markets